Characterization of Thymoma by Ultra-Performance Liquid Chromatography—High Resolution Mass Spectrometry (UPLC-HRMS) and Metabolomics of Serum

References

• Ackman, J. B. 2017. Corrigendum to 'High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts?' [EURR 84 (3) (2015) 524-533]. European Journal of Radiology 90:262–3. doi:10.1016/j.ejrad.2017.02.003.
   PubMed Web of Science ®Google Scholar
• Ackman, J. B., S. Verzosa, A. E. Kovach, A. Louissaint, Jr., M. Lanuti, C. D. Wright, J. O. Shepard, and E. F. Halpern. 2015. High rate of unnecessary thymectomy and its cause. Can computed tomography distinguish thymoma, lymphoma, thymic hyperplasia, and thymic cysts? European Journal of Radiology 84 (3):524–33. doi:10.1016/j.ejrad.2014.11.042.
   PubMed Web of Science ®Google Scholar
• Alwahsh, M., R. Knitsch, R. Marchan, J. Lambert, C. Hoerner, X. Zhang, B. Schalke, D.-H. Lee, E. Bulut, T. Graeter, et al. 2022. Metabolic profiling of thymic epithelial tumors hints to a strong Warburg Effect, glutaminolysis and precarious redox homeostasis as potential therapeutic targets. Cancers 14 (6):1564. doi:10.3390/cancers14061564.
   PubMed Web of Science ®Google Scholar
• Apostolova, P., and E. L. Pearce. 2022. Lactic acid and lactate: Revisiting the physiological roles in the tumor microenvironment. Trends in Immunology 43 (12):969–77. doi:10.1016/j.it.2022.10.005.
   PubMed Web of Science ®Google Scholar
• Battaglia, S., S. De Santis, M. Rutigliano, F. Sallustio, A. Picerno, M. A. Frassanito, I. Schaefer, A. Vacca, A. Moschetta, P. Seibel, et al. 2021. Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: A clinical pilot study. Scientific Reports 11 (1):12841. doi:10.1038/s41598-021-91559-8.
   PubMed Web of Science ®Google Scholar
• Benito, S., A. Sanchez-Ortega, N. Unceta, F. Andrade, L. Aldamiz-Echevarria, M. A. Goicolea, and R. J. Barrio. 2018a. Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS. The Analyst 143 (18):4448–58. doi:10.1039/c8an00864g.
   PubMed Web of Science ®Google Scholar
• Benito, S., A. Sanchez-Ortega, N. Unceta, J. J. Jansen, G. Postma, F. Andrade, L. Aldamiz-Echevarria, L. M. C. Buydens, M. A. Goicolea, and R. J. Barrio. 2018b. Plasma biomarker discovery for early chronic kidney disease diagnosis based on chemometric approaches using LC-QTOF targeted metabolomics data. Journal of Pharmaceutical and Biomedical Analysis 149:46–56. doi:10.1016/j.jpba.2017.10.036.
   PubMed Web of Science ®Google Scholar
• Berrih-Aknin, S., and R. Le Panse. 2014. Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. Journal of Autoimmunity 52:90–100. doi:10.1016/j.jaut.2013.12.011.
   PubMed Web of Science ®Google Scholar
• Blessin, N. C., P. Spriestersbach, W. Li, T. Mandelkow, D. Dum, R. Simon, C. Hube-Magg, F. Lutz, F. Viehweger, M. Lennartz, et al. 2020. Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms. Cellular Oncology (Dordrecht) 43 (3):421–30. doi:10.1007/s13402-020-00496-7.
   PubMed Web of Science ®Google Scholar
• Chocholoušková, M., R. Jirásko, D. Vrána, J. Gatěk, B. Melichar, and M. Holčapek. 2019. Reversed phase UHPLC/ESI-MS determination of oxylipins in human plasma: A case study of female breast cancer. Analytical and Bioanalytical Chemistry 411 (6):1239–51. doi:10.1007/s00216-018-1556-y.
   PubMed Web of Science ®Google Scholar
• Conforti, F., L. Pala, G. Giaccone, and T. De Pas. 2020. Thymic epithelial tumors: From biology to treatment. Cancer Treatment Reviews 86:102014. doi:10.1016/j.ctrv.2020.102014.
   PubMed Web of Science ®Google Scholar
• da Silva, E. F. G., K. G. Lima, G. C. Krause, G. V. Haute, L. Pedrazza, A. V. Catarina, R. B. Gassen, B. de Souza Basso, H. B. Dias, C. Luft, et al. 2020. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence. Investigational New Drugs 38 (6):1653–63. doi:10.1007/s10637-020-00941-2.
   PubMed Web of Science ®Google Scholar
• Du, X., L. Yu, F. Li, Z. Yu, X. G. Yang, Y. X. Jiang, and X. T. Yu. 2021. Case report: MDM4 amplified in a thymoma patient with autoimmune enteropathy and myocarditis. Frontiers in Immunology 12:661316.
   Google Scholar
• Edin, M. L., C. Duval, G. Zhang, and D. C. Zeldin. 2020. Role of linoleic acid-derived oxylipins in cancer. Cancer Metastasis Reviews 39 (3):581–2. doi:10.1007/s10555-020-09904-8.
   PubMed Web of Science ®Google Scholar
• Evans, D. R., and H. I. Guy. 2004. Mammalian pyrimidine biosynthesis: Fresh insights into an ancient pathway. The Journal of Biological Chemistry 279 (32):33035–8. doi:10.1074/jbc.R400007200.
   PubMed Web of Science ®Google Scholar
• Feng, J., H. Yang, Y. Zhang, H. Wei, Z. Zhu, B. Zhu, M. Yang, W. Cao, L. Wang, and Z. Wu. 2017. Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Oncogene 36 (42):5829–39. doi:10.1038/onc.2017.188.
   PubMed Web of Science ®Google Scholar
• Fischer, K., P. Hoffmann, S. Voelkl, N. Meidenbauer, J. Ammer, M. Edinger, E. Gottfried, S. Schwarz, G. Rothe, S. Hoves, et al. 2007. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109 (9):3812–9. doi:10.1182/blood-2006-07-035972.
   PubMed Web of Science ®Google Scholar
• Fu, J., M. Yu, W. Xu, and S. Yu. 2021. Research progress of bile acids in cancer. Frontiers in Oncology 11:778258. doi:10.3389/fonc.2021.778258.
   PubMed Web of Science ®Google Scholar
• Gika, H., C. Virgiliou, G. Theodoridis, R. S. Plumb, and I. D. Wilson. 2019. Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): The state of the art. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1117:136–47. doi:10.1016/j.jchromb.2019.04.009.
   PubMed Web of Science ®Google Scholar
• Giskeødegård, G. F., H. Bertilsson, K. M. Selnæs, A. J. Wright, T. F. Bathen, T. Viset, J. Halgunset, A. Angelsen, I. S. Gribbestad, and M.-B. Tessem. 2013. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness. PloS One 8 (4): E 62375. doi:10.1371/journal.pone.0062375.
   Web of Science ®Google Scholar
• Gu, X., J. Wu, X. Liu, Y. Hong, Y. Wu, and Y. Tian. 2022. Role of serum creatinine levels in prognostic risk stratification of prostate cancer patients. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 28:e937100. doi:10.12659/MSM.937100.
   PubMed Web of Science ®Google Scholar
• Guan, Y., A. Bhandari, X. Zhang, and O. Wang. 2019. Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines. Journal of Cellular and Molecular Medicine 23 (11):7438–48. doi:10.1111/jcmm.14612.
   PubMed Web of Science ®Google Scholar
• Guo, Y., X. Wang, L. Qiu, X. Qin, H. Liu, Y. Wang, F. Li, X. Wang, G. Chen, G. Song, et al. 2012. Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. Clinica Chimica Acta: International Journal of Clinical Chemistry 414:135–41. doi:10.1016/j.cca.2012.08.010.
   PubMed Web of Science ®Google Scholar
• Hackemer, P., B. Małkiewicz, F. Menzel, A. Drabik, K. Tupikowski, and R. Zdrojowy. 2021. Determinants of survival in patients with bladder cancer undergoing radical cystectomy: The impact of serum creatinine level. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 30 (1):77–82. doi:10.17219/acem/130597.
   PubMed Web of Science ®Google Scholar
• Haghikia, A., S. Jörg, A. Duscha, J. Berg, A. Manzel, A. Waschbisch, A. Hammer, D.-H. Lee, C. May, N. Wilck, et al. 2015. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43 (4):817–29. doi:10.1016/j.immuni.2015.09.007.
   PubMed Web of Science ®Google Scholar
• Han, Y.-S., L.-Y. Shi, J.-X. Chen, J. Chen, Z.-B. Li, Q.-Q. Lu, S.-Q. Zhang, J. Liu, W.-J. Yi, T.-T. Jiang, et al. 2022. Screening and identification of potential novel lipid biomarkers for non-small cell lung cancer using ultra-high performance liquid chromatography tandem mass spectrometry. Anatomical Record (Hoboken, N.J. 2007) 305 (5):1087–99. doi:10.1002/ar.24725.
   PubMedGoogle Scholar
• Hashimoto, N. 2020. Bile acids (taurocholic acid, taurodeoxycholic acid, taurochenodeoxycholic acid, tauroursodeoxycholic acid) develop esophageal cancer in a rat model of duodenoesophageal anastomosis after total gastrectomy. Annals of Esophagus 3:21– doi:10.21037/aoe-20-47.
   Google Scholar
• Hatae, R., K. Chamoto, Y. H. Kim, K. Sonomura, K. Taneishi, S. Kawaguchi, H. Yoshida, H. Ozasa, Y. Sakamori, M. Akrami, et al. 2020. Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy. JCI Insight 5 (2):e133501. doi:10.1172/jci.insight.133501.
   PubMed Web of Science ®Google Scholar
• Higuchi, R., T. Goto, Y. Hirotsu, S. Otake, T. Oyama, K. Amemiya, H. Ohyama, H. Mochizuki, and M. Omata. 2021. Sphingomonas and phenylobacterium as major microbiota in thymic epithelial tumors. Journal of Personalized Medicine 11 (11):1092. doi:10.3390/jpm11111092.
   PubMed Web of Science ®Google Scholar
• Huang, S., J. Li, N. L. Tam, C. Sun, Y. Hou, B. Hughes, Z. Wang, Q. Zhou, X. He, and L. Wu. 2019. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness. Molecular Carcinogenesis 58 (4):603–15. doi:10.1002/mc.22954.
   PubMed Web of Science ®Google Scholar
• Huang, J., B. Zhao, S. J. Weinstein, D. Albanes, and A. M. Mondul. 2022. Metabolomic profile of prostate cancer-specific survival among 1812 Finnish men. BMC Medicine 20 (1):362. doi:10.1186/s12916-022-02561-4.
   PubMed Web of Science ®Google Scholar
• Hung, M. H., J. S. Lee, C. Ma, L. P. Diggs, S. Heinrich, C. W. Chang, L. Ma, M. Forgues, A. Budhu, J. Chaisaingmongkol, et al. 2021. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nature Communications 12 (1):1455. doi:10.1038/s41467-021-21804-1.
   PubMed Web of Science ®Google Scholar
• Jakopovic, M., L. Bitar, F. Seiwerth, A. Marusic, K. Krpina, and M. Samarzija. 2020. Immunotherapy for thymoma. Journal of Thoracic Disease 12 (12):7635–41. doi:10.21037/jtd-2019-thym-12.
   PubMed Web of Science ®Google Scholar
• Jangi, S., L. Otterbein, and S. Robson. 2013. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. The International Journal of Biochemistry & Cell Biology 45 (12):2843–51. doi:10.1016/j.biocel.2013.09.014.
   PubMed Web of Science ®Google Scholar
• Kong, C., X. Yan, Y. Zhu, H. Zhu, Y. Luo, P. Liu, S. Ferrandon, M. F. Kalady, R. Gao, J. He, et al. 2021. Fusobacterium nucleatum promotes the development of colorectal cancer by activating a cytochrome P450/epoxyoctadecenoic acid axis via TLR4/Keap1/NRF2 signaling. Cancer Research 81 (17):4485–98. doi:10.1158/0008-5472.CAN-21-0453.
   PubMed Web of Science ®Google Scholar
• Konopelski, P., and I. Mogilnicka. 2022. Biological effects of indole-3-propionic acid, a gut microbiota-derived metabolite, and its precursor tryptophan in mammals’ health and disease. International Journal of Molecular Sciences 23 (3):1222. doi:10.3390/ijms23031222.
   PubMed Web of Science ®Google Scholar
• Lai, L. C., Q. L. Sun, Y. A. Chen, Y. W. Hsiao, T. P. Lu, M. H. Tsai, L. Zhu, E. Y. Chuang, and W. Fang. 2019. Using proteomic profiling to characterize protein signatures of different thymoma subtypes. BMC Cancer 19 (1):796. doi:10.1186/s12885-019-6023-4.
   PubMed Web of Science ®Google Scholar
• Lauritano, C., K. A. Martinez, P. Battaglia, A. Granata, M. de la Cruz, B. Cautain, J. Martin, F. Reyes, A. Ianora, and L. Guglielmo. 2020. First evidence of anticancer and antimicrobial activity in Mediterranean mesopelagic species. Scientific Reports 10 (1):4929. doi:10.1038/s41598-020-61515-z.
   PubMed Web of Science ®Google Scholar
• Li, C. X., H. Zhang, K. Wang, X. Wang, and X. C. Li. 2019. Preoperative bilirubin level predicts overall survival and tumor recurrence after resection for perihilar cholangiocarcinoma patients. Cancer Management and Research 11:10157–65. doi:10.2147/CMAR.S230620.
   PubMed Web of Science ®Google Scholar
• Liu, P., W. Zhu, C. Chen, B. Yan, L. Zhu, X. Chen, and C. Peng. 2020. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sciences 247:117443. doi:10.1016/j.lfs.2020.117443.
   PubMed Web of Science ®Google Scholar
• Luo, Y., H. Chen, R. Huang, Q. Wu, Y. Li, and Y. He. 2021. Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-kappaB signals in OVA-induced asthmatic mice. Pulmonary Pharmacology & Therapeutics 69:102049. doi:10.1016/j.pupt.2021.102049.
   PubMed Web of Science ®Google Scholar
• Marx, A., J. K. C. Chan, J.-M. Coindre, F. Detterbeck, N. Girard, N. L. Harris, E. S. Jaffe, M. O. Kurrer, E. M. Marom, A. L. Moreira, et al. 2015. The 2015 World Health Organization classification of tumors of the thymus: Continuity and changes. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 10 (10):1383–95. doi:10.1097/JTO.0000000000000654.
   PubMed Web of Science ®Google Scholar
• Marx, A., P. Ströbel, S. S. Badve, L. Chalabreysse, J. K. C. Chan, G. Chen, L. de Leval, F. Detterbeck, N. Girard, J. Huang, et al. 2014. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: Refined definitions, histological criteria, and reporting. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 9 (5):596–611. doi:10.1097/JTO.0000000000000154.
   PubMed Web of Science ®Google Scholar
• Meng, F. J., S. Wang, J. Zhang, Y. J. Yan, C. Y. Wang, C. R. Yang, Z. Y. Guan, and C. L. Wang. 2019. Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets. Thoracic Cancer 10 (5):1129–35. doi:10.1111/1759-7714.13053.
   PubMed Web of Science ®Google Scholar
• Muto, Y., and Y. Okuma. 2022. Therapeutic options in thymomas and thymic carcinomas. Expert Review of Anticancer Therapy 22 (4):401–13. doi:10.1080/14737140.2022.2052278.
   PubMed Web of Science ®Google Scholar
• Nasseri, F., and F. Eftekhari. 2010. Clinical and radiologic review of the normal and abnormal thymus: Pearls and pitfalls. Radiographics: A Review Publication of the Radiological Society of North America, Inc 30 (2):413–28. doi:10.1148/rg.302095131.
   PubMed Web of Science ®Google Scholar
• Nie, M., K. Yao, X. Zhu, N. Chen, N. Xiao, Y. Wang, B. Peng, L. Yao, P. Li, P. Zhang, et al. 2021. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma. Nature Communications 12 (1):6479. doi:10.1038/s41467-021-26685-y.
   PubMed Web of Science ®Google Scholar
• Nishino, M., S. K. Ashiku, O. N. Kocher, R. L. Thurer, P. M. Boiselle, and H. Hatabu. 2006. The thymus: A comprehensive review. Radiographics: A Review Publication of the Radiological Society of North America, Inc 26 (2):335–48. doi:10.1148/rg.262045213.
   PubMed Web of Science ®Google Scholar
• Nomair, A., M. Madkour, M. Shamseya, H. Elsheredy, and A. Shokr. 2019. Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma. Clinical and Experimental Hepatology 5 (4):317–26. doi:10.5114/ceh.2019.89478.
   PubMed Web of Science ®Google Scholar
• Ocvirk, S., and S. J. D. O'Keefe. 2021. Dietary fat, bile acid metabolism and colorectal cancer. Seminars in Cancer Biology 73:347–55. doi:10.1016/j.semcancer.2020.10.003.
   PubMed Web of Science ®Google Scholar
• Oktem, E. K., B. Aydin, G. Gulfidan, and K. Y. Arga. 2023. A transcriptomic and Reverse-Engineering strategy reveals molecular signatures of arachidonic acid metabolism in 12 Cancers. Omics: A Journal of Integrative Biology 27 (3):127–38. doi:10.1089/omi.2022.0185.
   PubMed Web of Science ®Google Scholar
• Ouldamer, L., M. L. Jourdan, M. Pinault, F. Arbion, and C. Goupille. 2022. Accumulation of arachidonic acid, precursor of pro-inflammatory eicosanoids, in adipose tissue of obese women: association with breast cancer aggressiveness indicators. Biomedicines 10 (5):995. doi:10.3390/biomedicines10050995.
   PubMed Web of Science ®Google Scholar
• Park, S. J., K. P. Lee, S. Kang, H. Y. Chung, Y. S. Bae, F. Okajima, and D. S. Im. 2013. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Cellular Signalling 25 (11):2147–54. doi:10.1016/j.cellsig.2013.07.001.
   PubMed Web of Science ®Google Scholar
• Patti, G. J., O. Yanes, and G. Siuzdak. 2012. Innovation: Metabolomics: The apogee of the omics trilogy. Nature Reviews. Molecular Cell Biology 13 (4):263–9. doi:10.1038/nrm3314.
   PubMed Web of Science ®Google Scholar
• Pero, R. W. 2010. Health consequences of catabolic synthesis of hippuric acid in humans. Current Clinical Pharmacology 5 (1):67–73. doi:10.2174/157488410790410588.
   PubMedGoogle Scholar
• Pillai, S. R., M. Damaghi, Y. Marunaka, E. P. Spugnini, S. Fais, and R. J. Gillies. 2019. Causes, consequences, and therapy of tumors acidosis. Cancer Metastasis Reviews 38 (1-2):205–22. doi:10.1007/s10555-019-09792-7.
   PubMed Web of Science ®Google Scholar
• Psychogios, N., D. D. Hau, J. Peng, A. C. Guo, R. Mandal, S. Bouatra, I. Sinelnikov, R. Krishnamurthy, R. Eisner, B. Gautam, et al. 2011. The human serum metabolome. PloS One 6 (2):e16957. doi:10.1371/journal.pone.0016957.
   PubMed Web of Science ®Google Scholar
• Roopashree, P. G., S. S. Shetty, and N. Suchetha Kumari. 2021. Effect of medium chain fatty acid in human health and disease. Journal of Functional Foods 87:104724. doi:10.1016/j.jff.2021.104724.
   Web of Science ®Google Scholar
• Rutkowsky, J. M., T. A. Knotts, K. D. Ono-Moore, C. S. McCoin, S. R. Huang, D. Schneider, S. Singh, S. H. Adams, and D. H. Hwang. 2014. Acylcarnitines activate proinflammatory signaling pathways. American Journal of Physiology: Endocrinology and Metabolism 306 (12):E1378–E1387. doi:10.1152/ajpendo.00656.2013.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133 (5):775–87. doi:10.1016/j.cell.2008.05.009.
   PubMed Web of Science ®Google Scholar
• Simmen, T., M. Nobile, J. S. Bonifacino, and W. Hunziker. 1999. Basolateral sorting of furin in MDCK cells requires a phenylalanine-isoleucine motif together with an acidic amino acid cluster. Molecular and Cellular Biology 19 (4):3136–44. doi:10.1128/MCB.19.4.3136.
   PubMed Web of Science ®Google Scholar
• Stępniak, J., J. Krawczyk-Lipiec, A. Lewiński, and M. Karbownik-Lewińska. 2022. Sorafenib versus lenvatinib causes stronger oxidative damage to membrane lipids in noncancerous tissues of the thyroid, liver, and kidney: Effective protection by melatonin and indole-3-propionic acid. Biomedicines 10 (11):2890. doi:10.3390/biomedicines10112890.
   PubMed Web of Science ®Google Scholar
• Stockert, J. A., R. Weil, K. K. Yadav, N. Kyprianou, and A. K. Tewari. 2021. Pseudouridine as a novel biomarker in prostate cancer. Urologic Oncology 39 (1):63–71. doi:10.1016/j.urolonc.2020.06.026.
   PubMed Web of Science ®Google Scholar
• Stolzenberg-Solomon, R., A. Derkach, S. Moore, S. J. Weinstein, D. Albanes, and J. Sampson. 2020. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study. Gut 69 (11):2008–15. doi:10.1136/gutjnl-2019-319811.
   PubMed Web of Science ®Google Scholar
• Suster, S., and C. A. Moran. 2008. Histologic classification of thymoma: The World Health Organization and beyond. Hematology/Oncology Clinics of North America 22 (3):381–92. doi:10.1016/j.hoc.2008.03.001.
   PubMed Web of Science ®Google Scholar
• Tang, E., Y. Zhou, S. Liu, Z. Zhang, R. Zhang, D. Huang, T. Gao, T. Zhang, and G. Xu. 2022. Metabolomic and transcriptomic profiling identified significant genes in thymic epithelial tumor. Metabolites 12 (6):567. doi:10.3390/metabo12060567.
   PubMed Web of Science ®Google Scholar
• Theodoridis, G., H. G. Gika, and I. D. Wilson. 2011. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrometry Reviews 30 (5):884–906. doi:10.1002/mas.20306.
   PubMed Web of Science ®Google Scholar
• Tong, T., J. Zhang, L. Jia, P. Liang, and N. Wang. 2022. Integrated proteomics and metabolomics analysis reveals hubs protein and network alterations in myasthenia gravis. Aging 14 (13):5417–26. doi:10.18632/aging.204156.
   PubMedGoogle Scholar
• Violante, S., L. Ijlst, H. T. Brinke, I. T. Almeida, R. J. A. Wanders, F. V. Ventura, and S. M. Houten. 2013. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines. FASEB Journal : official Publication of the Federation of American Societies for Experimental Biology 27 (5):2039–44. doi:10.1096/fj.12-216689.
   PubMed Web of Science ®Google Scholar
• Wang, H., J. Ding, S. Ding, and Y. Chang. 2019. Metabolomic changes and polyunsaturated fatty acid biosynthesis during gonadal growth and development in the sea urchin Strongylocentrotus intermedius. Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics 32:100611. doi:10.1016/j.cbd.2019.100611.
   PubMed Web of Science ®Google Scholar
• Wang, H. X., W. R. Pan, L. Zheng, X. P. Zhong, L. Tan, Z. F. Liang, J. He, P. F. Feng, Y. Zhao, and Y. R. Qiu. 2019. Thymic epithelial cells contribute to thymopoiesis and T cell development. Frontiers in Immunology 10:3099. doi:10.3389/fimmu.2019.03099.
   PubMed Web of Science ®Google Scholar
• Wang, P. P., X. Song, X. K. Zhao, M. X. Wei, S. G. Gao, F. Y. Zhou, X. N. Han, R. H. Xu, R. Wang, Z. M. Fan, et al. 2022. Serum metabolomic profiling reveals biomarkers for early detection and prognosis of esophageal squamous cell carcinoma. Frontiers in Oncology 12:790933. doi:10.3389/fonc.2022.790933.
   PubMed Web of Science ®Google Scholar
• Wang, J., S. Xu, W. Lv, F. Shi, S. Mei, A. Shan, J. Xu, and Y. Yang. 2020. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma. Cancer Medicine 9 (16):5940–7. doi:10.1002/cam4.3251.
   PubMed Web of Science ®Google Scholar
• Wang, Z., L. Y. Yip, J. H. J. Lee, Z. Wu, H. Y. Chew, P. K. W. Chong, C. C. Teo, H. Y.-K. Ang, K. L. E. Peh, J. Yuan, et al. 2019. Methionine is a metabolic dependency of tumor-initiating cells. Nature Medicine 25 (5):825–37. doi:10.1038/s41591-019-0423-5.
   PubMed Web of Science ®Google Scholar
• Wei, Y., P. Jasbi, X. Shi, C. Turner, J. Hrovat, L. Liu, Y. Rabena, P. Porter, and H. Gu. 2021. Early breast cancer detection using untargeted and targeted metabolomics. Journal of Proteome Research 20 (6):3124–33. doi:10.1021/acs.jproteome.1c00019.
   PubMed Web of Science ®Google Scholar
• Wei, J., Z. Liu, K. Wu, D. Yang, Y. He, G. G. Chen, J. Zhang, and J. Lin. 2017. Identification of prognostic and subtype-specific potential miRNAs in thymoma. Epigenomics 9 (5):647–57. doi:10.2217/epi-2016-0161.
   PubMed Web of Science ®Google Scholar
• Wolf, P. G., H. R. Gaskins, J. M. Ridlon, S. Freels, A. Hamm, S. Goldberg, P. Petrilli, T. Schering, S. Vergis, S. Gomez-Perez, et al. 2020. Effects of taurocholic acid metabolism by gut bacteria: A controlled feeding trial in adult African American subjects at elevated risk for colorectal cancer. Contemporary Clinical Trials Communications 19:100611. doi:10.1016/j.conctc.2020.100611.
   PubMed Web of Science ®Google Scholar
• Wu, Y., M. Jamal, T. Xie, J. Sun, T. Song, Q. Yin, J. Li, S. Pan, X. Zeng, S. Xie, et al. 2019. Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer. Cancer Science 110 (9):2734–47. doi:10.1111/cas.14125.
   PubMed Web of Science ®Google Scholar
• Xie, L.-M., L.-F. Yau, Z.-H. Jiang, L.-Y. Zhang, Y. Xia, and J.-R. Wang. 2017. Sphingolipidomic study of davidiin-treated HepG2 human hepatocellular carcinoma cells using UHPLC-MS. RSC Advances 7 (87):55249–56. doi:10.1039/C7RA11266A.
   Web of Science ®Google Scholar
• Yamada, Y., C. A. Weis, J. Thelen, C. Sticht, B. Schalke, P. Strobel, and A. Marx. 2020. Thymoma associated myasthenia gravis (TAMG): Differential expression of functional pathways in relation to MG status in different thymoma histotypes. Frontiers in Immunology 11:664. doi:10.3389/fimmu.2020.00664.
   PubMed Web of Science ®Google Scholar
• Yokoyama, S., and H. Miyoshi. 2020. Comparison of PD-L1 immunohistochemical assays and the significance of PD-L1 expression in thymoma. Journal of Thoracic Disease 12 (12):7553–60. doi:10.21037/jtd-19-3703.
   PubMed Web of Science ®Google Scholar
• Yu, Z., G. Kastenmüller, Y. He, P. Belcredi, G. Möller, C. Prehn, J. Mendes, S. Wahl, W. Roemisch-Margl, U. Ceglarek, et al. 2011. Differences between human plasma and serum metabolite profiles. PloS One 6 (7):e21230. doi:10.1371/journal.pone.0021230.
   PubMed Web of Science ®Google Scholar
• Zang, X., J. Zhang, P. Jiao, X. Xue, and Z. Lv. 2022. Non-small cell lung cancer detection and subtyping by UPLC-HRMS-based tissue metabolomics. Journal of Proteome Research 21 (8):2011–22. doi:10.1021/acs.jproteome.2c00316.
   PubMedGoogle Scholar
• Zhang, A., H. Sun, and X. Wang. 2012. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Analytical and Bioanalytical Chemistry 404 (4):1239–45. doi:10.1007/s00216-012-6117-1.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., X. Chen, C. He, G. Gao, Z. Chen, and J. Du. 2021. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity. Bioorganic & Medicinal Chemistry Letters 51:128361. doi:10.1016/j.bmcl.2021.128361.
   PubMed Web of Science ®Google Scholar
• Zheng, H., B. Dong, J. Ning, X. Shao, L. Zhao, Q. Jiang, H. Ji, A. Cai, W. Xue, and H. Gao. 2020. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry 501:241–51. doi:10.1016/j.cca.2019.10.046.
   PubMed Web of Science ®Google Scholar